Total liabilities · 2011–2025
Elite Pharmaceuticals total liabilities
$46.1M−15.1% · FY2025
Elite Pharmaceuticals (ELTP) reported $46.1M in total liabilities for fiscal 2025, −15.1% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $46.1M | −15.1% | Open → |
| FY20242024-12-31 | $54.3M | +92.0% | Open → |
| FY20232023-12-31 | $28.3M | +25.5% | Open → |
| FY20222022-12-31 | $22.5M | +146.2% | Open → |
| FY20212021-12-31 | $9.2M | −23.9% | Open → |
| FY20202020-12-31 | $12.0M | −19.8% | Open → |
| FY20192019-12-31 | $15.0M | +17.8% | Open → |
| FY20182018-12-31 | $12.7M | +4.6% | Open → |
| FY20172017-12-31 | $12.2M | +20.0% | Open → |
| FY20162016-12-31 | $10.2M | −65.2% | Open → |
| FY20152015-12-31 | $29.2M | −48.1% | Open → |
| FY20142014-12-31 | $56.2M | +142.4% | Open → |
| FY20132013-12-31 | $23.2M | +2.1% | Open → |
| FY20122012-12-31 | $22.7M | −7.8% | Open → |
| FY20112011-12-31 | $24.7M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +4.6%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals total liabilities |url=https://companiesranked.com/en/company/elite-pharmaceuticals/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals total liabilities. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/total-liabilitiesBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001493152-26-007104 · February 17, 2026
{{cite web |title=Elite Pharmaceuticals total liabilities — 10-Q (0001493152-26-007104) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226007104/form10-q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.